0001702123-20-000002.txt : 20201215 0001702123-20-000002.hdr.sgml : 20201215 20201215135610 ACCESSION NUMBER: 0001702123-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201215 DATE AS OF CHANGE: 20201215 EFFECTIVENESS DATE: 20201215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiol Therapeutics Inc. CENTRAL INDEX KEY: 0001702123 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383247 FILM NUMBER: 201389149 BUSINESS ADDRESS: STREET 1: 2275 UPPER MIDDLE ROAD EAST, STE. 101 CITY: OAKVILLE STATE: A6 ZIP: L6H 0C3 BUSINESS PHONE: 905-491-6793 MAIL ADDRESS: STREET 1: 2275 UPPER MIDDLE ROAD EAST, STE. 101 CITY: OAKVILLE STATE: A6 ZIP: L6H 0C3 D 1 primary_doc.xml X0708 D LIVE 0001702123 Cardiol Therapeutics Inc. 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 289-910-0850 ONTARIO, CANADA None None Corporation true 2017 David Elsley 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Executive Officer Director Promoter Eldon R. Smith 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Executive Officer Director Promoter Deborah Brown 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Iain Chalmers 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Peter Pekos 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Dr. Guillermo Torre-Amione 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Colin Stott 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Director Chris Waddick 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Executive Officer Thomas Moffatt 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Executive Officer Anthony Bolton 2265 Upper Middle Road East Suite 602 Oakville A6 ONTARIO, CANADA L6H 0G5 Promoter Pharmaceuticals No Revenues 06b false 2020-06-04 true true true true true Each Unit consists of one common share and one-half of one share purchase warrant. Each warrant is exercisable for one common share at an exercise price of Cdn$3.25 per common share for a period of 24 months. false 0 CANACCORD GENUITY LLC 1020 None None 535 MADISON AVENUE NEW YORK NY NEW YORK 10022 FL FLORIDA PA PENNSYLVANIA false 9129776 829139 8300637 The additional $8,300,637 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. The U.S. dollar amount is based on the Bank of Canada daily average rate of exchange reported on 6/4/2020, which was Cdn$1.3508=USD$1.00 false 2 24874 true 0 Additionally, 13,440 broker warrants are exercisable into units at Cdn$2.50. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Cardiol Therapeutics Inc. Dan Crandall Dan Crandall Director of Finance 2020-12-11